002720.KS
Kukje Pharma Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 3,385.00
−0.88%Year over year
Reported trailing growth
- Revenue
- +8.0%
- EBITDA
- -73.3%
- EBIT
- -46.9%
- EPS
- -23.6%
- Free cash flow
- -64.2%
- Operating cash flow
- -22.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +11.5%
- EBITDA
- -2.8%
- EBIT
- +5.5%
- Net income
- +17.0%
- EPS
- +16.8%
- Free cash flow
- -24.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026